FDA Approves Updated Label for Miach Orthopaedics’ BEAR® Implant to Include Significantly Lower Risk of Osteoarthritis
6x Higher Rate of Post-Traumatic Osteoarthritis (PTOA) for ACL Reconstruction Compared to BEAR Implant Observed in BEAR I and II Studies WESTBOROUGH, Massachusetts – January 14, 2026 – Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears, today announced that the U.S. Food and [...]